Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

author_full_names

Rinaldi, Ikhwan (23475122400); Pratama, Samuel (57209511731); Wiyono, Lowilius (57207889054); Tandaju, Jeremy Rafael (57222662533); Wardhana, Indy Larasati (57866827000); Winston, Kevin (57224165400)

authors

Rinaldi I.; Pratama S.; Wiyono L.; Tandaju J.R.; Wardhana I.L.; Winston K.

title

Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis

source_title

Frontiers in Oncology

abstract

Patient populations, including those with hematological malignancies, have different responses to COVID-19 vaccines. This study aimed to quantitatively analyze the efficacy and safety of COVID-19 mRNA vaccines in patients with hematological malignancies.

author_keywords

adverse effects; antibody titers; COVID-19; hematologic malignancies; mRNA vaccine; seroconversion rates

funding_texts

correspondence_address

I. Rinaldi; Hematology and Medical Oncology Division, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; email: This email address is being protected from spambots. You need JavaScript enabled to view it.

publisher

Frontiers Media S.A.

issn

2234943X

pubmed_id

abbreviated_source_title

Front. Oncol.

authors_with_affiliations

Rinaldi I., Hematology and Medical Oncology Division, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Pratama S., Faculty of Medicine, Uni

affiliations

Hematology and Medical Oncology Division, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Hospital Medicine, Bhakti Medicare Hospital, Cic

author_s_id

23475122400; 57209511731; 57207889054; 57222662533; 57866827000; 57224165400

cited_by

year

2022

link

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136969028&doi=10.3389%2ffonc.2022.951215&partnerID=40&md5=1156629a34e837804d1fb2dfcbb1522a

document_type

Article